Parental Satisfaction With Sumatriptan Nasal Spray in Childhood Migraine

Abstract

Migraine headaches are a frequently encountered neurologic problem in children. The utility of the triptans has not been as clearly documented in this population, although it is well delineated in acute migraine attacks in adults. We conducted a retrospective chart review of our experience with using sumatriptan nasal spray in children aged 5 to 12 years from our headache clinic population with migraine headaches. The nasal spray formulation is used frequently in our clinic population with patients who have failed over-the-counter therapy with ibuprofen or acetaminophen. None of the triptans are approved by the US Food and Drug Administration for use in children or adolescents (12 years and older). One hundred of these patients were identified, and their parents or guardians completed a standardized questionnaire regarding their child's response to sumatriptan nasal spray in acute migraine. Fifty-seven of 100 families completed the questionnaire, and 44 of 57 families (77%) reported good to excellent relief of their child's migraine attacks with sumatriptan nasal spray. In our cohort of pediatric patients, sumatriptan nasal spray was effective and well tolerated when used for abortive therapy of acute migraine attacks. (J Child Neurol 2003;18:772—775).

Get full access to this article

View all access options for this article.

References

Abu-Arafeh I. , Russel G. : Prevalence of headache and migraine in school children. BMJ 1994;309:765—769.

Brown EG , Endersby CA , Smith RN , Talbot Jcc : The safety and tolerability of sumatriptan: An overview. Eur Neurol 1991; 31:339—344.

Ueberall MA , Wenzel D. : Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999;52:1507—1510.

Rothner AD , Winner P. , Nett R. , et al: One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: Results of a multicenter open-label study. Clin Ther 2000; 22:1533—1546.

Tepper SJ : Safety and rational use of the triptans, in Mathew N (ed): “Headache” in The Medical Clinics of North America. Philadelphia, WB Saunders, 2001, 959—970.

Hershey AD , Powers SW , LeCates S. , Bentti AL : Effectiveness of nasal sumatriptan in 5- to 12-year-old children. Headache 2001;41:693—697.

Winner P. , Rothner AD , Saper J. , et al: A randomized double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106:989—997.

Maytal J. , Young M. , Shechter A. , Lipton RB : Pediatric migraine and the International Headache Society (IHS) criteria. Neurology 1997;48:602-607.

Hamalainen ML , Hoppu K. , Santavuori P. : Sumatriptan for migraine attacks in children: A randomized placebo-controlled study—Do children with migraine respond to oral sumatriptan differently from adults? Neurology 1997;48:1100—1103.

10.

Hamalainen ML , Hoppu K. , Valkeila E. , Santavuori P. : Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study. Neurology 1997;48:103—107.